The marijuana stock market has seen quite the amount of publicity over the course of the past few years. With so much changing including laws and the public perception of the substance, it seems only fitting that companies would be working hard to meet these future goals. The companies at the top of the industry continue to be those who grow the substance in its raw form, and they are working to produce large quantities of cannabis. Although some have stated that we are seeing an undersupply, it looks as though there are many companies that are working to solve this.
Nabis Holdings (INNPF/NAB) is one of the leading investment issuers working out of the Canadian space. Although they are headquartered in Canada, many of their operations have since been seen in the U.S. market. The company has been working throughout the various facets of the industry to continue providing investors with the best situation possible. For those who don’t know, the co-founders of Nabis Holdings previously led MPX Bioceutical to the largest cannabis takeover in the U.S. marijuana space to date. With sight set high on revenue generation and growth in the vertical aspect of the industry, Nabis Holdings continues to be a promising company to keep an eye on.
The company recently announced that they have completed their investment in both Battle Creek and Constantine, Michigan, for the provisioning centers that they have located there. The goal is to target the Michigan cannabis market which has become one of the fastest booming markets in the nation despite it only being around for a short period of time. Additionally, they have also stated that they are working to complete their other three provisioning centers in the state which should be announced within the coming weeks.
Once they are finished with these acquisitions, they should have as many as seven provisioning centers in the state with plans to add as many as ten to fifteen more. This should help them on their way to moving deeper into the U.S. cannabis market one step at a time. Shay Shnet, CEO of Nabis Holdings stated that “we continue to cement our foundation in Michigan with the completion of our investments in the Battle Creek and Constantine provisioning centers. With additional provisioning centers, we believe Nabis is well positioned in the largest medical licensing cannabis market in the U.S.”
Cara Therapeutics (CARA) is a company that operates in the ancillary market for cannabis. The company is a producer of pharmaceuticals that has seen a large amount of success in recent times. With their drugs receiving approvals from the FDA in the U.S., they definitely look like they are on the right track.
One of the things to keep in mind, however, is that Cara has been known to be quite volatile along with many other stocks in the industry. This, however, has its positives and negatives. The best advice here is to simply do the research and know what investing style fits best.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Nabis Holdings (OTC:INNPF) (CSE:NAB), Midam has been paid $250,000 by Nabis Holdings (OTC:INNPF) (CSE:NAB) for a period from January 22, 2019 to April 22, 2019. We may buy or sell additional shares of (OTC:INNPF) (CSE:NAB) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Nabis Holdings (OTC:INNPF) (CSE:NAB).